Karsten Wassermann

2.9k total citations
64 papers, 2.4k citations indexed

About

Karsten Wassermann is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Karsten Wassermann has authored 64 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Organic Chemistry. Recurrent topics in Karsten Wassermann's work include DNA Repair Mechanisms (10 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Metabolism, Diabetes, and Cancer (9 papers). Karsten Wassermann is often cited by papers focused on DNA Repair Mechanisms (10 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Metabolism, Diabetes, and Cancer (9 papers). Karsten Wassermann collaborates with scholars based in Denmark, United States and Norway. Karsten Wassermann's co-authors include Vilhelm A. Bohr, Tinna Stevnsner, Christian L. Brand, Jesper Damgaard, Kurt W. Kohn, Glenn L. Wilson, Susan P. LeDoux, E J Beecham, Lars Andrup and Philip J. Larsen and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Science of The Total Environment.

In The Last Decade

Karsten Wassermann

64 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karsten Wassermann Denmark	28	1.5k	383	358	312	284	64	2.4k
Cécile Mazière France	31	1.2k 0.8×	243 0.6×	241 0.7×	395 1.3×	310 1.1×	119	2.9k
Reidar Wallin United States	40	1.6k 1.0×	483 1.3×	177 0.5×	199 0.6×	448 1.6×	100	4.0k
Kurt M. Bohren United States	31	1.9k 1.3×	506 1.3×	244 0.7×	205 0.7×	475 1.7×	54	3.6k
G. Béréziat France	34	1.4k 0.9×	296 0.8×	204 0.6×	467 1.5×	525 1.8×	148	3.2k
Jack Y. Vanderhoek United States	26	878 0.6×	269 0.7×	123 0.3×	393 1.3×	364 1.3×	66	2.6k
Kathleen T. Shiverick United States	30	959 0.6×	392 1.0×	291 0.8×	139 0.4×	190 0.7×	88	2.7k
Rachel Hertz Israel	27	1.7k 1.1×	194 0.5×	329 0.9×	491 1.6×	505 1.8×	56	2.3k
Birgitta Rosengren Sweden	26	1.1k 0.7×	329 0.9×	128 0.4×	563 1.8×	227 0.8×	42	2.4k
Louis Douste‐Blazy France	33	1.7k 1.1×	335 0.9×	125 0.3×	556 1.8×	606 2.1×	159	3.3k
Kou‐Yi Tserng United States	27	1.1k 0.7×	202 0.5×	333 0.9×	172 0.6×	521 1.8×	74	2.4k

Countries citing papers authored by Karsten Wassermann

Since Specialization

Citations

This map shows the geographic impact of Karsten Wassermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Wassermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Wassermann more than expected).

Fields of papers citing papers by Karsten Wassermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten Wassermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Wassermann. The network helps show where Karsten Wassermann may publish in the future.

Co-authorship network of co-authors of Karsten Wassermann

This figure shows the co-authorship network connecting the top 25 collaborators of Karsten Wassermann. A scholar is included among the top collaborators of Karsten Wassermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karsten Wassermann. Karsten Wassermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lyby, Karsten, et al.. (2019). The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects. Clinical Pharmacokinetics. 58(11). 1497–1504. 23 indexed citations

Lyby, Karsten, et al.. (2019). Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial. The Lancet Diabetes & Endocrinology. 7(3). 179–188. 123 indexed citations

Larsen, Philip J., Kirsten Lykkegaard, Leif K. Larsen, et al.. (2008). Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-γ) agonist balaglitazone. European Journal of Pharmacology. 596(1-3). 173–179. 34 indexed citations

Hansen, Lars, et al.. (2006). The Pro12Ala Variant of the PPARG Gene Is a Risk Factor for Peroxisome Proliferator-Activated Receptor-γ/α Agonist-Induced Edema in Type 2 Diabetic Patients. The Journal of Clinical Endocrinology & Metabolism. 91(9). 3446–3450. 32 indexed citations

Pickavance, Lucy, Christian L. Brand, Karsten Wassermann, & John Wilding. (2005). The dual PPARα/γ agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats. British Journal of Pharmacology. 144(3). 308–316. 64 indexed citations

Wassermann, Karsten, et al.. (2003). Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists. Journal of Molecular Endocrinology. 30(3). 317–329. 27 indexed citations

Sturis, Jeppe, C. F. Gotfredsen, John Rømer, et al.. (2003). GLP‐1 derivative liraglutide in rats with β‐cell deficiencies: influence of metabolic state on β‐cell mass dynamics. British Journal of Pharmacology. 140(1). 123–132. 176 indexed citations

Bury, Paul S., Birgit Sehested Hansen, Susan M. Thorpe, et al.. (2002). Synthesis and biological evaluation of novel thio-substituted chromanes as high-affinity partial agonists for the estrogen receptor. Bioorganic & Medicinal Chemistry Letters. 12(1). 17–19. 6 indexed citations

Bury, Paul S., Poul Jacobsen, Anker Jørgensen, et al.. (2002). Synthesis and pharmacological evaluation of novel cis-3,4-Diaryl-hydroxychromanes as high affinity partial agonists for the estrogen receptor. Bioorganic & Medicinal Chemistry. 10(1). 125–145. 22 indexed citations

10.

Möller, Peter, Karsten Wassermann, Jesper Damgaard, Bjørn A. Nexø, & Håkan Wallin. (2000). Sensitivity to Nitrogen Mustard Relates to the Ability of Processing DNA Damage in Chinese Hamster Ovary Cells. Pharmacology & Toxicology. 86(4). 169–177. 7 indexed citations

11.

Jørgensen, Anker, Poul Jacobsen, Paul S. Bury, et al.. (2000). Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives. Bioorganic & Medicinal Chemistry Letters. 10(20). 2383–2386. 34 indexed citations

12.

Jørgensen, Anker, Paul S. Bury, Anders Kanstrup, et al.. (2000). Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd]indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor. Bioorganic & Medicinal Chemistry Letters. 10(4). 399–402. 37 indexed citations

13.

Andrup, Lars, Jesper Damgaard, Karsten Wassermann, et al.. (1994). Complete Nucleotide Sequence of the Bacillus thuringiensis subsp. israelensis Plasmid pTX14-3 and Its Correlation with Biological Properties. Plasmid. 31(1). 72–88. 26 indexed citations

14.

Wassermann, Karsten. (1994). Intragenomic Heterogeneity of DNA Damage Formation and Repair: A Review of Cellular Responses to Covalent Drug DNA Interaction. Critical Reviews in Toxicology. 24(4). 281–322. 14 indexed citations

15.

Wassermann, Karsten, P M O'Connor, Joany Jackman, Alfred May, & Vilhelm A. Bohr. (1994). Transcription-independent repair of nitrogen mustard-induced N-alkylpurines in the c-myc gene in Burkitt's lymphoma CA46 cells. Carcinogenesis. 15(9). 1779–1783. 2 indexed citations

16.

Poulsen, Henrik E., Steffen Loft, & Karsten Wassermann. (1993). Cancer Risk Related to Genetic Polymorphisms in Carcinogen Metabolism and DNA Repair. Pharmacology & Toxicology. 72(s1). 93–103. 26 indexed citations

17.

Knudsen, Lisbeth E., Jan Christensen, Jens Erik Jelnes, et al.. (1992). Biomonitoring of genotoxic exposure among stainless steel welders. Mutation Research/Genetic Toxicology. 279(2). 129–143. 50 indexed citations

18.

Wassermann, Karsten, J. William Lown, J.A. Hartley, et al.. (1990). Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.. PubMed. 50(6). 1732–7. 3 indexed citations

19.

Krarup‐Hansen, Anders, et al.. (1988). Pharmacokinetics of Doxorubicin in Man with Induced Acid or Alkaline Urine. Acta Oncologica. 27(1). 25–30. 15 indexed citations

20.

Wassermann, Karsten, et al.. (1988). A possible role for altered poly(adenosine diphosphoribose)-synthesis in the sensitivity of human head and neck squamous carcinoma cells to ionizing radiation. Biochemical and Biophysical Research Communications. 154(3). 1041–1046. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact